MID-VOLUME · FEMALE-LED
meclizine Side Effects
meclizine (also sold as Antivert, Bonine) sits MID-VOLUME #268 of 524 by FAERS report count. Lead signal: FEMALE-LED - 74% of sex-coded reports are female (10,928 F / 3,808 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 15,616
- FAERS reports
FDA Adverse Event Reporting System extract for meclizine. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
meclizine reporting skew - 74% of sex-coded reports are female (10,928 F / 3,808 M). Volume band MID-VOLUME #268 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for meclizine (Antivert) (15,616 reports). Signature FEMALE-LED. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
DIZZINESS leads 1,570 of 15,616 reports
FEMALE-LED reporters · age peak 45-64
Female-led reporters (74% of sex-coded rows)
Age peak 45-64 (3,350 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,426 reports, 9.1%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 530 |
| COMPLETED SUICIDE | 180 |
| TOXICITY TO VARIOUS AGENTS | 133 |
| RENAL FAILURE | 109 |
| CHRONIC KIDNEY DISEASE | 101 |
| ACUTE KIDNEY INJURY | 93 |
| NAUSEA | 78 |
| PNEUMONIA | 77 |
| FALL | 76 |
| ASTHENIA | 70 |
| CARDIAC FAILURE CONGESTIVE | 70 |
| DYSPNOEA | 68 |
| PAIN | 68 |
| END STAGE RENAL DISEASE | 66 |
| FATIGUE | 66 |
| DIZZINESS | 62 |
| CARDIAC ARREST | 60 |
| DIARRHOEA | 59 |
| HYPOTENSION | 57 |
| ANXIETY | 51 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (4,910, 31.4% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DIZZINESS | 560 |
| FALL | 560 |
| NAUSEA | 500 |
| DYSPNOEA | 410 |
| PAIN | 400 |
| ASTHENIA | 393 |
| FATIGUE | 388 |
| DIARRHOEA | 358 |
| PNEUMONIA | 356 |
| VOMITING | 333 |
| HEADACHE | 301 |
| URINARY TRACT INFECTION | 291 |
| ANXIETY | 267 |
| CHEST PAIN | 266 |
| CEREBROVASCULAR ACCIDENT | 260 |
| VERTIGO | 249 |
| ACUTE KIDNEY INJURY | 242 |
| RENAL FAILURE | 233 |
| HYPERTENSION | 230 |
| DEHYDRATION | 228 |
How to read meclizine FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 15,616 voluntary reports linked to meclizine (Antivert, Bonine), 2004-2025. Death is listed on 1,426 (9.1%). Hospitalization appears on 4,910 (31.4%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 74% of sex-coded reports are female (10,928 F / 3,808 M).
Read with meclizine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 15,513 FAERS cases (Δ 103 lighter vs meclizine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 15,755 FAERS cases (Δ 139 heavier vs meclizine); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 15,757 FAERS cases (Δ 141 heavier vs meclizine); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 15,783 FAERS cases (Δ 167 heavier vs meclizine); DEATH-MARKED · HOSP-LIGHT · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 53.0 pp vs meclizine's DEATH-HEAVY): CASELOAD · HOSP-MID.
meclizine stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.